73MO Regorafenib in patients (pts) with unresectable hepatocellular carcinoma (uHCC) in real-world practice in Asia: Final analysis of the prospective, observational REFINE study

Autor:	Y.J. Kim, M. Kurosaki, K. Numata, H.Y. Lim, M. Ikeda, M. Kudo, Y-H. Huang, G. Shao, N. Kato, D-Y. Kim, S-B. Cho, C-H. Hsu, S-M. Lin, L-B. Jeng, K-K. Kuo, Y. Mao, B. Chewaskulyong, J. Khan, K. Ozgurdal, S. Qin
Rok vydání:	2022
Předmět:	Oncology Hematology
Zdroj:	Annals of Oncology. 33:S1459-S1460
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2022.10.109
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::64ef0ada80b29dcb7ae86dc6351150d8 https://doi.org/10.1016/j.annonc.2022.10.109 Zobrazit plný text záznamu